Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Cyanation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102746185B details a green synthesis of aromatic nitriles using potassium ferrocyanide, offering high purity and reduced toxicity for reliable pharmaceutical intermediate supply chains.
Discover the clean production method for 2-fluoro-4-nitrobenzonitrile via patent CN103694137A, offering reduced waste and energy-efficient manufacturing for kinase inhibitors.
Novel air-oxidation method reduces cost and pollution for agrochemical intermediate manufacturing with high yield. Our scalable process ensures reliable supply and environmental compliance for global partners seeking efficient thiocyanation solutions.
Novel route for VX-960 intermediate via cyanation and resolution. High purity, mild conditions, cost-effective manufacturing for global supply chains.
Novel nickel-catalyzed cyanation route for high-purity pharma intermediates. Delivers significant cost reduction in pharma manufacturing and reliable supply chain continuity.
Novel patent CN114751853B enables safer synthesis of key antiviral intermediates. Achieve high purity and yield without toxic cyanide. Reliable supply chain partner.
Novel palladium-catalyzed cyanation using potassium ferrocyanide ensures high purity and yield. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN101759591A reveals a greener Agomelatine synthesis using cyclohexane and one-pot acetylation, offering significant cost reduction and high purity for API manufacturers.
Patent CN110240554B reveals a novel silver-catalyzed cyanation route. This report analyzes cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing.
Patent CN119080657B reveals efficient copper catalyzed route. Delivers supply chain stability and cost optimization for global pharmaceutical intermediate manufacturing partners.
Patent CN111533662B details a cost-effective synthesis of citalopram intermediates using accessible halogenated benzoic acids, offering significant supply chain advantages.
Patent CN101113138B details a safe cyanation method using ferrocene imine cyclopalladium complexes. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel four-step synthesis of Sarpyridan using DMF and ammonium iodide. Offers cost reduction in API manufacturing and reliable pharmaceutical intermediate supplier solutions.
Novel two-step synthesis from styrene reduces cost and improves purity for pharmaceutical manufacturing supply chains.
Patent CN116332794A reveals a safe Pd-catalyzed cyanation using K4[Fe(CN)6], offering high purity aryl nitriles for pharma intermediates with reduced toxicity.
Novel synthesis route for 5-cyano-3-methylpicolinic acid ensures high purity and cost efficiency for pharmaceutical manufacturing supply chains globally.
Patent CN116283661B reveals a low cost synthesis route for this key agrochemical intermediate ensuring high purity and scalable supply chain reliability for global buyers.
Patent CN114133323B reveals a safe TMSCN-based route for morphine precursors, offering significant yield improvements and cost reduction in API manufacturing.
Patent CN120117998A reveals cost-effective route for apalutamide intermediate ensuring supply chain stability and reduced manufacturing complexity for global buyers.
This patent details a low-cost environmentally friendly febuxostat preparation method enhancing supply chain reliability and reducing manufacturing costs for global pharmaceutical partners.